Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis
Open Access
- 1 January 2020
- journal article
- review article
- Published by Elsevier in Annals of Intensive Care
- Vol. 10 (1) , 132-19
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcomeCritical Care, 2013
- Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trialCritical Care, 2013
- Shock Index and Early Recognition of Sepsis in the Emergency Department: Pilot StudyWestern Journal of Emergency Medicine, 2013
- Early natural killer cell counts in blood predict mortality in severe sepsisCritical Care, 2011
- Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patientsCritical Care, 2011
- Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patientsCritical Care, 2011
- Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveCritical Care, 2011
- Sepsis, complement and the dysregulated inflammatory responseJournal of Cellular and Molecular Medicine, 2009
- EFFECTS OF IGM-ENRICHED SOLUTION ON POLYMORPHONUCLEAR NEUTROPHIL FUNCTION, BACTERIAL CLEARANCE, AND LUNG HISTOLOGY IN ENDOTOXEMIAShock, 2008
- MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsisJournal of Experimental Medicine, 2007